NCT04632368

Brief Summary

This single blind, randomized, controlled trial (RCT) evaluates, a nonpharmacological intervention, TM (Transcendental Meditation) for improving burnout (, as measured by self-reporting (survey), physiologic, and neuro-functional imaging studies in health care providers (HCPs) when practiced over 3 months' time. The investigators define HCPs as any physician, physician trainee, nurse, physician assistant, nurse practitioner or respiratory therapist. HCPs will be screened by a single-item stress scale and Columbia Suicide Severity Rating Scale (CSSRS) to understand their stress level and exclusion criteria respectively. The Global Severity Index of the Brief Symptom Inventory (BSI)-18 Global Severity score will be used as the primary outcome for pre- and post-TM training (baseline, 1 vs. 3 months). In addition, the investigators will evaluate physiological markers of stress and cardiovascular resiliency such as 1) changes (pre/post-treatment) in heart rate variability (HRV) through wearables, 2) Galvanic Skin Response (GSR) - changes in sweat gland activity that result from changes in an emotional state. fMRI will be performed by the Duke Brain Imaging and Analysis Center (BIAC) on a subset of participants to evaluate changes A specifically developed mobile app will aid data collection as well as reminders for providers to aid compliance for meditation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 17, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

November 20, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2021

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2021

Completed
Last Updated

August 23, 2021

Status Verified

May 1, 2021

Enrollment Period

9 months

First QC Date

November 11, 2020

Last Update Submit

August 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in self reported Stress symptoms

    Changes in brief symptom inventory as evaluated by BSI 18

    Baseline, 1 month, 3 months

Secondary Outcomes (6)

  • Change in self reported resilience

    Baseline, 1 month, 3 months

  • Change in symptoms of depression

    Baseline, 1 month, 3 months

  • Change in insomnia symptoms

    Baseline, 1 month, 3 months

  • Change in anxiety symptoms

    Baseline, 1 month, 3 months

  • Change in psychological distress

    Baseline, 1 month, 3 months

  • +1 more secondary outcomes

Study Arms (2)

Transcendental Meditation Intervention Arm

ACTIVE COMPARATOR

TM, a mind-body intervention that can reduce sympathetic arousal and promote a state of relaxation and calm, will be offered to a randomized group of eligible HCPs ( N=40)providing care during COVID-19 pandemic.

Behavioral: Transcendental Meditation

Treatment as usual(TAU) Control Arm

NO INTERVENTION

Control group consists of eligible HCPs who are randomized to control group(N=40) and would not receive any intervention. At the end of 3 month study period, control group participants would be eligible for TM training.

Interventions

TM, a mind-body intervention that can reduce sympathetic arousal and promote a state of relaxation and calm, will be offered to HCPs dealing with COVID-19 pandemic

Transcendental Meditation Intervention Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HCPs including physicians, trainee physicians, nurses, nurse practitioners, Physician Assistants, and respiratory therapists providing patient care during the COVID-19 pandemic.
  • Subjects who have at least a 5% increase from baseline in heart rate after exposure to a personalized stressful script OR at least a 33% increase in skin conductance after exposure to the script
  • Willingness to address burnout symptoms by non-pharmacological means
  • All subjects must provide Informed Consent prior to enrollment in the study.
  • Willingness to wear the provided Apple Watch for the data collection process

You may not qualify if:

  • Antipsychotic medications or beta-blockers
  • Current suicidal or homicidal ideation (suicidal ideation as screened by C-SSRI survey pre-enrollment)
  • Previous instruction in TM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University health system

Durham, North Carolina, 27710, United States

Location

Related Publications (1)

  • Joshi SP, Wong AI, Brucker A, Ardito TA, Chow SC, Vaishnavi S, Lee PJ. Efficacy of Transcendental Meditation to Reduce Stress Among Health Care Workers: A Randomized Clinical Trial. JAMA Netw Open. 2022 Sep 1;5(9):e2231917. doi: 10.1001/jamanetworkopen.2022.31917.

MeSH Terms

Conditions

Burnout, ProfessionalStress, Psychological

Interventions

Meditation

Condition Hierarchy (Ancestors)

Occupational StressOccupational DiseasesBurnout, PsychologicalBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Eligible participants, on enrollment in the study, would be randomly assigned to meditation intervention group vs control group. Control group will be offered intervention at the end of the study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2020

First Posted

November 17, 2020

Study Start

November 20, 2020

Primary Completion

August 10, 2021

Study Completion

August 16, 2021

Last Updated

August 23, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations